Back to TRUIST FINANCIAL CORP TRUIST FINANCIAL CORP

ONCYONCY
1 quarters

Position history for TRUIST FINANCIAL CORPTRUIST FINANCIAL CORP's holdings in ONCOLYTICS BIOTECH INC

Yes. Truist Financial holds 20,000 shares of ONCY (Oncolytics Biotech), worth $19,000, as of its Q2 2026 13F filing.

Current Value

$19,000

Current Shares

20,000

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
20,000
-
$19,0000.0%$0.95
28

Other major holders of ONCY: MARSHALL WACE, LLP, XTX Topco Ltd, GOLDMAN SACHS GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used